Clinical Endocrinology · 1983 · 27 citations · 20 references
MedicineEndocrinologyPharmacologyEndocrine PharmacotherapyNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyDopaminergic PharmacologyDopaminergic SignalingHormonal InfluencesHormonal TherapyProlactin DisordersDomperidone TherapyDopamine D1-like ReceptorsDopamine D2-like ReceptorsDopamine Endocrine RegulationDopamine Inhibition Of ProlactinDopamine Receptor AgonistsProlactin Secretion RegulationResponsiveness
The TSH and PRL responses to administration of the two dopamine (DA) receptor antagonists sulpiride and domperidone, were studied in fifteen normoprolactinaemic subjects, twenty-two post-partum women and sixteen subjects with presumptive evidence of (six subjects) or surgically confirmed (ten subjects) prolactinomas. Sulpiride (100 mg i.m.) or domperidone (10 mg i.v.) elicited a slight increase in basal TSH levels in both normoprolactinaemic and post-partum women, but induced a clear-cut TSH rise in subjects with a tumour. Conversely, sulpiride and domperidone strikingly stimulated PRL secretion in normoprolactinaemic and post-partum women, but only slightly enhanced base-line PRL levels in women with prolactinomas. The reason for the reciprocal pattern of TSH and PRL responsiveness to DA receptor blockade of post-partum women and subjects with prolactinomas is presently obscure. Since baseline PRL levels in the two hyperprolactinaemic states overlapped widely, it would appear that hyperprolactinaemia per se is not responsible for such behaviour.
20
Frontiers in Neuroendocrinology
Joseph Ball · The Journal of Nervous and Mental Disease · 1975 · 429 citations
Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin Release
Vincent Raymond, Michele J. Beaulieu, Fernand Labrie et al. · Science · 1978 · 383 citations